Effect of a phosphodiesterase 3 inhibitor, cilostazol, on bronchial hyperresponsiveness in elderly patients with asthma. [electronic resource]
Producer: 19980120Description: 379-84 p. digitalISSN:- 1018-2438
- 3',5'-Cyclic-AMP Phosphodiesterases -- antagonists & inhibitors
- Administration, Oral
- Aged
- Asthma -- drug therapy
- Bronchial Hyperreactivity -- drug therapy
- Cilostazol
- Cyclic Nucleotide Phosphodiesterases, Type 3
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Phosphodiesterase Inhibitors -- administration & dosage
- Respiratory Function Tests
- Tetrazoles -- administration & dosage
- Theophylline -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.